| 000 | 01075 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250518035340.0 | ||
| 264 | 0 | _c20191230 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 024 | 7 |
_a10.3324/haematol.2018.214536 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, William | |
| 245 | 0 | 0 |
_aMogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all? _h[electronic resource] |
| 260 |
_bHaematologica _c05 2019 |
||
| 300 |
_a864-867 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukemia-Lymphoma, Adult T-Cell |
| 650 | 0 | 4 | _aLymphoma |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aMishra, Anjali | |
| 700 | 1 | _aBinder, Adam | |
| 700 | 1 | _aGru, Alejandro | |
| 700 | 1 | _aPorcu, Pierluigi | |
| 773 | 0 |
_tHaematologica _gvol. 104 _gno. 5 _gp. 864-867 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2018.214536 _zAvailable from publisher's website |
| 999 |
_c29642695 _d29642695 |
||